Uterine leiomyomas reportedly emerge through at least three distinct genetic drivers: mutations in the mediator complex subunit 12 or fumarate hydratase or genomic rearrangement of high mobility group at-hook 2 [28]. Here, MED12 is linked to Uterine leiomyoma.